8
Aug
2023
Digging into Data, Finding New Drug Targets: Colin Hill on The Long Run
Today’s guest on The Long Run is Colin Hill. He’s the co-founder and CEO of Aitia (pronounced Ay-tee-ah). The company was founded in 2000, and previously known as GNS Healthcare. The GNS part was short for Gene Network Sciences, which gives you some sense of what it was about. Aitia is a new name to reflect a new strategy. The... Read More
8
Aug
2023
Recursion Screens Protein-Small Molecule Interactions at Vast Scale
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.